CRNX Stock Analysis: Buy, Sell, or Hold?
CRNX - Crinetics Pharmaceuticals, Inc.
$84.81
0.12 (0.14%)
▲
5d:
+0.07%
30d:
+1.29%
90d:
+130.46%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 10, 2026 at $84.15 · last confirmed Aug 18, 2026
Strength: 4.6/10
Get Alerted When CRNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CRNX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CRNX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRNX is currently trading at $84.81, which is considered extended relative to its 30-day fair value range of $83.68 to $84.45.
Technical Outlook: Technically, CRNX is in a strong uptrend. The price is currently testing key support at $84.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRNX is in a strong uptrend. The price is currently testing key support at $84.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$83.68 -
$84.45
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($85.50)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$83.68 -
$84.45
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$84.20
Resistance Level
$84.81
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-21.15
Wall Street Target
$85.50
(+1.0%)
Revenue Growth (YoY)
2336.3%
Share & Embed Analysis
Last updated: August 24, 2026 2:09 PM ET
Data refreshes hourly during market hours. Next update: 3:09 PM
Data refreshes hourly during market hours. Next update: 3:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRNX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeff E Knight
SELL
85163 shares
2026-04-08
Jeff E Knight
SELL
9911 shares
2026-03-16
Richard Scott Struthers
SELL
21981 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 34 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 39 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 50 HOLD |
